Kynurenine Pathway in Chronic Kidney Disease: What's Old, What's New, and What's Next?

Int J Tryptophan Res. 2020 Sep 21:13:1178646920954882. doi: 10.1177/1178646920954882. eCollection 2020.

Abstract

Impaired kidney function and increased inflammatory process occurring in the course of Chronic Kidney Disease (CKD) contribute to the development of complex amino-acid alterations. The essential amino-acid tryptophan (TRP) undergoes extensive metabolism along several pathways, resulting in the production of many biologically active compounds. The results of many studies have shown that its metabolism via the kynurenine pathway is potently increased in the course of CKD. Metabolites of this pathway exhibit differential, sometimes opposite, roles in several biological processes. Their accumulation in the course of CKD may induce oxidative cell damage which stimulates inflammatory processes. They can also modulate the activity of numerous cellular signaling pathways through activation of the aryl hydrocarbon receptor, leading to the disruption of homeostasis of various organs. As a result, they can contribute to the development of the systemic disorders accompanying the course of chronic renal failure. This review gathers and systematizes reports concerning the knowledge connecting the kynurenine pathway metabolites to systemic disorders accompanying the development of CKD.

Keywords: Tryptophan; chronic kidney disease; kynurenine; mineral and bone disorders; neurological disorders; thrombosis.

Publication types

  • Review